Treatment of primary sjögren's syndrome with low‐dose human interferon alfa administered by the oromucosal route: Combined phase III results

J. Cummins, Martin; Papas, Athena; M. Kammer, Gary; C. Fox, Philip

doi:10.1002/art.11199

Public

Treatment of primary sjögren's syndrome with low‐dose human interferon alfa administered by the oromucosal route: Combined phase III results

Published in Arthritis Care & Research • Aug 1, 2003

Authors:

Martin J. Cummins

Athena Papas

Gary M. Kammer

Abstract

OBJECTIVE: This study tested the safety and efficacy of human interferon (IFN) alfa for treatment of salivary hypofunction and dry mouth symptoms in primary Sjögren's syndrome patients. METHODS: Combined results are reported from 2 phase III clinical trials in which a total of 497 subjects with prim...

Subject

Medicine

Placebo

Adverse effect

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!